Laboratory Testing for Diagnosing Calciphylaxis

Understanding Calciphylaxis

• Vascular calcification leading to ischemic skin ulceration is a characteristic of calciphylaxis, a rare and life-threatening complication of chronic kidney disease-mineral and bone disorder (CKD-MBD) 1, 3

Diagnostic Approach

Laboratory Testing Limitations

• Serum calcium and phosphate levels are not predictive of outcomes in calciphylaxis and cannot be reliably used for guiding therapy, according to the Kidney International guidelines 1, 2, 3
• C-reactive protein is the most helpful laboratory test in diagnosing calciphylaxis, as it reflects the inflammatory component of the condition, as recommended by the Journal of Allergy and Clinical Immunology 4

Histopathological Diagnosis Challenges

• Skin biopsy has significant limitations, including no established features or validated histologic diagnostic criteria, and variable sensitivity (20-80%), as reported in Kidney International 1
• Inadequate sampling in 30% of biopsies and risk of traumatizing vulnerable tissue are additional challenges in histopathological diagnosis, according to Kidney International 1

Risk Factors and Associated Conditions

• High doses of active vitamin D derivatives and vitamin K antagonism or deficiency are risk factors for calciphylaxis, as identified in Kidney International 1, 3
• Inflammation, detected by elevated C-reactive protein, is also a risk factor, as noted in Kidney International and Journal of Allergy and Clinical Immunology 1, 4
• Use of vitamin K antagonists increases the risk of calciphylaxis up to 11-fold, according to Kidney International 1, 3

Treatment Implications

• C-reactive protein levels can help monitor inflammatory response to treatment, as suggested by the Journal of Allergy and Clinical Immunology 4
• SNF472 (hexaphosphate phytate) has shown promise in clinical trials for calciphylaxis, with improvements in wound healing and reduced hospitalizations, as reported in Kidney International 1, 2